- Home
- AVIR vs CLW Comparison
AVIR vs CLW Comparison
Compare AVIR & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | CLW |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 288.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | CLW |
|---|---|---|
| Price | $3.93 | $17.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $6.00 | ★ $27.00 |
| AVG Volume (30 Days) | ★ 452.4K | 202.1K |
| Earning Date | 03-05-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 875.72 |
| EPS | N/A | ★ 8.63 |
| Revenue | N/A | ★ $1,556,100,000.00 |
| Revenue This Year | N/A | $13.33 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.01 |
| Revenue Growth | N/A | ★ 23.00 |
| 52 Week Low | $2.46 | $16.44 |
| 52 Week High | $4.34 | $33.57 |
Technical Indicators
Market Signals| Indicator | AVIR | CLW |
|---|---|---|
| Relative Strength Index (RSI) | 61.08 | 36.68 |
| Support Level | $3.75 | $17.69 |
| Resistance Level | $4.15 | $18.63 |
| Average True Range (ATR) | 0.22 | 0.76 |
| MACD | 0.04 | -0.30 |
| Stochastic Oscillator | 58.51 | 14.18 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.